Kaplan-Meier analysis (https://kmplot.com/analysis/, accessed on 1 April 2022) revealed a significant reduction in overall survival (OS) (Figure 1B) and progression-free survival (PFS) times (Figure 1C) in HBV-related HCC patients with underexpressed FXR. Here, NR1H4 is linked to hepatocellular carcinoma.